Pages that link to "Q35831438"

The following pages link to Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease (Q35831438):

Displaying 22 items.

• Human herpesvirus 6 (Q24683663) (← links)
• Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light chain-restricted monotypic B-cell neoplasm (Q30444995) (← links)
• Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 (Q33265945) (← links)
• Epstein–Barr virus and Hodgkin’s lymphoma in Cairo, Egypt (Q33906890) (← links)
• Detection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization. (Q33962280) (← links)
• Hodgkin's lymphoma: the pathologist's viewpoint (Q34564836) (← links)
• EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management (Q35040644) (← links)
• Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group (Q35763601) (← links)
• Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease (Q35795547) (← links)
• Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes (Q36646940) (← links)
• The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential (Q36685081) (← links)
• The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. (Q36686042) (← links)
• Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein-Barr virus (Q37270264) (← links)
• Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells (Q38322174) (← links)
• Detection and characterization of Epstein-Barr virus in clinical specimens. (Q40684609) (← links)
• The small RNAs of Epstein-Barr virus (Q40852581) (← links)
• Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. (Q42013581) (← links)
• CD8(+) T cells in Hodgkin's disease tumor tissue are a polyclonal population with limited clonal expansion but little evidence of selection by antigen (Q42856838) (← links)
• Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study. (Q45775063) (← links)
• Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease (Q45787074) (← links)
• New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. (Q47353782) (← links)
• Pathobiology of hodgkin lymphoma (Q56986903) (← links)